|
1
|
Carvalho AL, Nishimoto IN, Califano JA and
Kowalski LP: Trends in incidence and prognosis for head and neck
cancer in the United States: A site-specific analysis of the SEER
database. Int J Cancer. 114:806–816. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chu W, Song X, Yang X, Ma L, Zhu J, He M,
Wang Z and Wu Y: Neuropilin-1 promotes epithelial-to-mesenchymal
transition by stimulating nuclear factor-kappa B and is associated
with poor prognosis in human oral squamous cell carcinoma. PLoS
One. 9:e1019312014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lafon-Hughes L, Di Tomaso MV, Méndez-Acuña
L and Martinez-López W: Chromatin-remodelling mechanisms in cancer.
Mutat Res. 658:191–214. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Backs J and Olson EN: Control of cardiac
growth by histone acetylation/deacetylation. Circ Res. 98:15–24.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ito K, Ito M, Elliott WM, Cosio B,
Caramori G, Kon OM, Barczyk A, Hayashi S, Adcock IM, Hogg JC and
Barnes PJ: Decreased histone deacetylase activity in chronic
obstructive pulmonary disease. N Engl J Med. 352:1967–1976. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Brandl A, Wagner T, Uhlig KM, Knauer SK,
Stauber RH, Melchior F, Schneider G, Heinzel T and Krämer OH:
Dynamically regulated sumoylation of HDAC2 controls p53
deacetylation and restricts apoptosis following genotoxic stress. J
Mol Cell Biol. 4:284–293. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xu WS, Parmigiani RB and Marks PA: Histone
deacetylase inhibitors: Molecular mechanisms of action. Oncogene.
26:5541–5552. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li Y, Liu T, Ivan C, Huang J, Shen DY,
Kavanagh JJ, Bast RC Jr, Fu S, Hu W and Sood AK: Enhanced cytotoxic
effects of combined valproic acid and the aurora kinase inhibitor
VE465 on gynecologic cancer cells. Front Oncol. 3:582013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wedel S, Hudak L, Seibel JM, Makarević J,
Juengel E, Tsaur I, Wiesner C, Haferkamp A and Blaheta RA: Impact
of combined HDAC and mTOR inhibition on adhesion, migration and
invasion of prostate cancer cells. Clin Exp Metastasis. 28:479–491.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dong LH, Cheng S, Zheng Z, Wang L, Shen Y,
Shen ZX, Chen SJ and Zhao WL: Histone deacetylase inhibitor
potentiated the ability of MTOR inhibitor to induce autophagic cell
death in Burkitt leukemia/lymphoma. J Hematol Oncol. 6:532013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mazurkiewicz-Beldzińska M, Szmuda M and
Matheisel A: Long-term efficacy of valproate versus lamotrigine in
treatment of idiopathic generalized epilepsies in children and
adolescents. Seizure. 19:195–197. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ullmann R, Chien CD, Avantaggiati ML and
Muller S: An acetylation switch regulates SUMO-dependent protein
interaction networks. Mol Cell. 46:759–770. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wilkinson KA and Henley JM: Mechanisms,
regulation and consequences of protein SUMOylation. Biochem J.
428:133–145. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Drag M and Salvesen GS: DeSUMOylating
enzymes-SENPs. IUBMB Life. 60:734–742. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Katayama A, Ogino T, Bandoh N, Takahara M,
Kishibe K, Nonaka S and Harabuchi Y: Overexpression of small
ubiquitin-related modifier-1 and sumoylated Mdm2 in oral squamous
cell carcinoma: Possible involvement in tumor proliferation and
prognosis. Int J Oncol. 31:517–524. 2007.PubMed/NCBI
|
|
16
|
Ding X, Sun J, Wang L, Li G, Shen Y, Zhou
X and Chen W: Overexpression of SENP5 in oral squamous cell
carcinoma and its association with differentiation. Oncol Rep.
20:1041–1045. 2008.PubMed/NCBI
|
|
17
|
Sun Z, Hu S, Luo Q, Ye D, Hu D and Chen F:
Overexpression of SENP3 in oral squamous cell carcinoma and its
association with differentiation. Oncol Rep. 29:1701–1706.
2013.PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xing B, Liang XP, Liu P, Zhao Y, Chu Z and
Dang YH: Valproate inhibits methamphetamine induced hyperactivity
via glycogen synthase kinase 3β signaling in the nucleus accumbens
core. PLoS One. 10:e1280682015. View Article : Google Scholar
|
|
20
|
Xing B, Zhao Y, Zhang H, Dang Y, Chen T,
Huang J and Luo Q: Microinjection of valproic acid into the
ventrolateral orbital cortex exerts an antidepressant-like effect
in the rat forced swim test. Brain Res Bull. 85:153–157. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao Y, Xing B, Dang YH, Qu CL, Zhu F and
Yan CX: Microinjection of valproic acid into the ventrolateral
orbital cortex enhances stress-related memory formation. PLoS One.
8:e526982013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Garcia H, Fleyshman D, Kolesnikova K,
Safina A, Commane M, Paszkiewicz G, Omelian A, Morrison C and
Gurova K: Expression of FACT in mammalian tissues suggests its role
in maintaining of undifferentiated state of cells. Oncotarget.
2:783–796. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tripi TR, Bonaccorso A, Rapisarda E and
Bartoloni G: Proliferative activity in periapical lesions. Aust
Endod J. 29:31–33. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Praefcke GJ, Hofmann K and Dohmen RJ: SUMO
playing tag with ubiquitin. Trends Biochem Sci. 37:23–31. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Juengel E, Makarević J, Tsaur I, Bartsch
G, Nelson K, Haferkamp A and Blaheta RA: Resistance after chronic
application of the HDAC-inhibitor valproic acid is associated with
elevated Akt activation in renal cell carcinoma in vivo. PLoS One.
8:e531002013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Miller CP, Ban K, Dujka ME, McConkey DJ,
Munsell M, Palladino M and Chandra J: NPI-0052, a novel proteasome
inhibitor, induces caspase-8 and ROS-dependent apoptosis alone and
in combination with HDAC inhibitors in leukemia cells. Blood.
110:267–277. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Boku S, Nakagawa S, Masuda T, Nishikawa H,
Kato A, Takamura N, Omiya Y, Kitaichi Y, Inoue T and Kusumi I:
Valproate recovers the inhibitory effect of dexamethasone on the
proliferation of the adult dentate gyrus-derived neural precursor
cells via GSK-3beta and beta-catenin pathway. Eur J Pharmacol.
723:425–430. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Brunn J, Wiroth V, Kowalski M, Runge U and
Sabolek M: Valproic acid in normal therapeutic concentration has no
neuroprotective or differentiation influencing effects on long term
expanded murine neural stem cells. Epilepsy Res. 108:623–633. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Valdés-Mora F, Song JZ, Statham AL,
Strbenac D, Robinson MD, Nair SS, Patterson KI, Tremethick DJ,
Stirzaker C and Clark SJ: Acetylation of H2A.Z is a key epigenetic
modification associated with gene deregulation and epigenetic
remodeling in cancer. Genome Res. 22:307–321. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu S, Klisovic RB, Vukosavljevic T, Yu J,
Paschka P, Huynh L, Pang J, Neviani P, Liu Z, Blum W, et al:
Targeting AML1/ETO-histone deacetylase repressor complex: A novel
mechanism for valproic acid-mediated gene expression and cellular
differentiation in AML1/ETO-positive acute myeloid leukemia cells.
J Pharmacol Exp Ther. 321:953–960. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Leiva M, Moretti S, Soilihi H, Pallavicini
I, Peres L, Mercurio C, Dal Zuffo R, Minucci S and de Thé H:
Valproic acid induces differentiation and transient tumor
regression, but spares leukemia-initiating activity in mouse models
of APL. Leukemia. 26:1630–1637. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Driever PH, Wagner S, Hofstädter F and
Wolff JE: Valproic acid induces differentiation of a supratentorial
primitive neuroectodermal tumor. Pediatr Hematol Oncol. 21:743–751.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gan CP, Hamid S, Hor SY, Zain RB, Ismail
SM, Mustafa W, Mahadzir W, Teo SH, Saunders N and Cheong SC:
Valproic acid: Growth inhibition of head and neck cancer by
induction of terminal differentiation and senescence. Head Neck.
34:344–353. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Suzuki T, Yokozaki H, Kuniyasu H, Hayashi
K, Naka K, Ono S, Ishikawa T, Tahara E and Yasui W: Effect of
trichostatin A on cell growth and expression of cell cycle- and
apoptosis-related molecules in human gastric and oral carcinoma
cell lines. Int J Cancer. 88:992–997. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cappadocia L, Mascle XH, Bourdeau V,
Tremblay-Belzile S, Chaker-Margot M, Lussier-Price M, Wada J,
Sakaguchi K, Aubry M, Ferbeyre G and Omichinski JG: Structural and
functional characterization of the phosphorylation-dependent
interaction between PML and SUMO1. Structure. 23:126–138. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sharma P, Yamada S, Lualdi M, Dasso M and
Kuehn MR: Senp1 is essential for desumoylating Sumo1-modified
proteins but dispensable for Sumo2 and Sumo3 deconjugation in the
mouse embryo. Cell Rep. 3:1640–1650. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Madu IG, Namanja AT, Su Y, Wong S, Li YJ
and Chen Y: Identification and characterization of a new chemotype
of noncovalent SENP inhibitors. ACS Chem Biol. 8:1435–1441. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wen D, Xu Z, Xia L, Liu X, Tu Y, Lei H,
Wang W, Wang T, Song L, Ma C, et al: Important role of SUMOylation
of Spliceosome factors in prostate cancer cells. J Proteome Res.
13:3571–3582. 2014. View Article : Google Scholar : PubMed/NCBI
|
